Literature DB >> 7984717

Correlation between depression and vision in aged patients before and after cataract operations.

R Fagerström1.   

Abstract

To investigate the association between depression and vision, 100 cataract operation patients (25 were men and 75 women) aged 71 to 76 years were studied. One day before the operation and 3 mo. after, the patients' depression was tested with the short form of the Beck Depression Inventory and their personalities with Mini-Mult MMPI. The cataract operation restored visual acuity sufficient for reading (minimum E-test value 0.40) to 79% of the subjects. The analysis indicated that their depression was significantly correlated with vision only after the cataract operation. Depression increased with weakened visual acuity and diminished with improved visual acuity. Part of the postoperation depression was, however, associated with glaucoma and serious somatic diseases (asthma, cerebrovascular disorders, and heart diseases).

Entities:  

Mesh:

Year:  1994        PMID: 7984717     DOI: 10.2466/pr0.1994.75.1.115

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  4 in total

1.  Eye Care Disparities and Health-Related Consequences in Elderly Patients with Age-Related Eye Disease.

Authors:  Allison C Umfress; Milam A Brantley
Journal:  Semin Ophthalmol       Date:  2016-04-26       Impact factor: 1.975

2.  Improvement in Cognitive Status and Depressive Symptoms Three Months after Cataract Surgery.

Authors:  Farzan Kheirkhah; GholamAbbas Roustaei; Elham Mohebbi Abivardi; Angela Hamidia; Sakineh Javadian Kutenai
Journal:  Caspian J Intern Med       Date:  2018

3.  Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults.

Authors:  Ranmalee Eramudugolla; Joanne Wood; Kaarin J Anstey
Journal:  Front Aging Neurosci       Date:  2013-10-02       Impact factor: 5.750

4.  Coping style and quality of life in elderly patients with vision disturbances.

Authors:  Maria Oles; Piotr Oles
Journal:  J Ophthalmol       Date:  2014-08-21       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.